Amarin (AMRN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings ...

Craig-Hallum analyst Greg Palm maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) today. The company’s shares opened today at $5.65. See what stocks are receiving ...

MIRA Pharmaceuticals (MIRA) announced the approval and upcoming initiation of its Phase 1 clinical trial for Ketamir-2, the Company’s novel ...

Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

The month of November saw a number of notable hires and personnel moves in biotech and pharma. Read on for a round-up of some of the biggest moves that crossed our desks. AstraZeneca hires new SVP ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

Merck & Co. Inc. 0.87% $235.4B ...

Repurchase of Common & Preferred Stk. Repurchase of Common & Preferred Stk.

After hours: February 28 at 7:55:36 PM EST Loading Chart for PHIO ...